| Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus JM Belardinelli, D Verma, W Li, C Avanzi, CJ Wiersma, JT Williams, ... Science translational medicine 14 (633), eabj3860, 2022 | 22 | 2022 |
| Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo C Pearce, MM Ruth, LJ Pennings, HFL Wertheim, A Walz, W Hoefsloot, ... Journal of Antimicrobial Chemotherapy 75 (7), 1889-1894, 2020 | 20 | 2020 |
| Preclinical evaluation of inhalational spectinamide-1599 therapy against tuberculosis M Gonzalez-Juarrero, PB Lukka, S Wagh, A Walz, J Arab, C Pearce, Z Ali, ... ACS infectious diseases 7 (10), 2850-2863, 2021 | 15 | 2021 |
| Mycobacterium leprae infection in a wild nine-banded armadillo, Nuevo León, Mexico L Vera-Cabrera, CJ Ramos-Cavazos, NA Youssef, CM Pearce, ... Emerging Infectious Diseases 28 (3), 747, 2022 | 8 | 2022 |
| Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3 UA Ochsner, MA De Groote, TC Jarvis, H Liu, T Youmans, T Hoang, ... Tuberculosis 138, 102288, 2023 | 5 | 2023 |
| Respirable clofazimine particles produced by air jet milling technique are efficacious in treatment of BALB/c mice with chronic Mycobacterium tuberculosis infection AD Brunaugh, A Walz, Z Warnken, C Pearce, J Munoz Gutierrez, ... Antimicrobial Agents and Chemotherapy 66 (9), e00186-22, 2022 | 5 | 2022 |
| A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides MZ Ali, TS Dutt, A MacNeill, A Walz, C Pearce, H Lam, JS Philp, ... Elife 13, RP96190, 2024 | 4 | 2024 |
| Role of succinyl substituents in the mannose-capping of lipoarabinomannan and control of inflammation in Mycobacterium tuberculosis infection Z Palčeková, A Obregón-Henao, K De, A Walz, H Lam, J Philp, SK Angala, ... PLoS Pathogens 19 (9), e1011636, 2023 | 4 | 2023 |
| Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies A Walz, PB Lukka, C Pearce, E Creissen, M Braunstein, AJ Hickey, ... Tuberculosis 117, 52-55, 2019 | 4 | 2019 |
| Development of a mucoadhesive liquid crystal system for the administration of rifampicin applicable in tuberculosis therapy KP Santos, CF Rodero, CM Ribeiro, MPD Gremião, RG Peccinini, ... Life 12 (8), 1138, 2022 | 3 | 2022 |
| 566 Repurposing antimalarials drugs for the treatment of nontuberculous mycobacterium infections J Belardinelli, D Verma, W Li, C Avanzi, C Wiersma, J Williams, ... Journal of Cystic Fibrosis 21, S315, 2022 | 1 | 2022 |
| Mycobacterium abscessus pulmonary infection and associated respiratory function in cystic fibrosis-like βENaC mice CM Pearce, TD Shaw, B Podell, M Jackson, M Henao-Tamayo, ... Frontiers in Tuberculosis 2, 1473341, 2024 | | 2024 |
| Preclinical in vivo assessment of replacing linezolid for spectinamide-1599 in the Nix-TB regimen MZ Ali, TS Dutt, A Walz, C Pearce, RE Lee, GT Robertson, AJ Hickey, ... The Journal of Immunology 208 (1_Supplement), 165.21-165.21, 2022 | | 2022 |
| Inhaled tigecycline induces change in immune cell modulation that synergizes with antimicrobial activity in chronic pulmonary Mycobacterium abscessus disease CM Pearce, A Walz, M Gonzalez-Juarrero, Z Ali, J Munoz-Gutierrez, ... The Journal of Immunology 204 (1_Supplement), 75.23-75.23, 2020 | | 2020 |
| Inhalational antibiotic therapy for treatment of chronic pulmonary Mycobacterium abscessus disease in mice C Pearce, M Gonzalez-Juarrero, M Jackson, J Volckens Colorado State University. Libraries, 2019 | | 2019 |
| NON-TUBERCULOUS MYCOBACTERIUM PULMONARY DISEASE: CHALLENGES AND STRATEGIES FOR THE PRECLINICAL MODELING OF M. ABSCESSUS AND M. AVIUM COMPLEX C Pearce, M Gonzalez-Juarrero, M Jackson, M Henao-Tamayo, ... Colorado State University. Libraries, 0 | | |
